• Luis Blanco, Centro de Biología Molecular Severo Ochoa (CSIC). Madrid

• Agnès Gruart , División de Neurocencias. U. Pablo Olavide. Sevilla

• Francisco M Sánchez-Margallo, Centro de Cirugía de Mínima Invasión Jesús Usón. Cáceres

• Jeff Bacher, Genetic Analysis Group, Promega Corporation, Madison (WI)

• Simon Melov, Buck Institute for Age Research. Novato.CA.

• Juan Bueren, División de Hematopoyesis y Terapia Génica (CIEMAT). Madrid

• Thomas Tuschl, Laboratory of RNA Molecular Biology, The Rockefeller University, New York (NY)

• Peter Carmeliet , Center for Transgene Technology and Gene Therapy. Leuven (Bélgica)

• Jesús Almendral, Unidad de Electrofisiología del Hospital Gregorio Marañón. Madrid

• María Blasco , Centro Nacional de Investigaciones Oncológicas. Madrid

• Manuel Serrano , Centro Nacional de Investigaciones Oncológicas. Madrid

• M.A. Ramírez , Dpto. de Reproducción Animal. INIA. Madrid

• Judith Campisi, Buck Institute for Age Research. Novato . CA (USA)

• José M Delgado, División de Neurocencias. U. Pablo Olavide. Sevilla

• Juan Cruz Cigudosa, Centro Nacional de Investigaciones Oncológicas. Madrid

• Isidro Sánchez-García , Centro de Investigación del Cáncer. Salamanca

• Fernando Larcher , U. de Epitelios. CIEMAT. Madrid

• Enrique de la Rosa , Centro de Investigaciones Biológicas (CSIC). Madrid

• Alfonso Fairén, Instituto de Neurociencias. Alicante

• Antonio Bernad Miana
• Platform Director
• Ext.3300

Antonio Bernad Miana studied Chemical Sciences at the Universidad de Zaragoza and moved to the Universidad Autónoma de Madrid to specialize in Biochemistry and Molecular Biology (1980-84). He went on to complete his PhD (1985-89) at the Centro de Biología Molecular Severo Ochoa (Madrid) under the supervision of Margarita Salas and Luis Blanco. From 1990 to 1993 he worked as a Senior Researcher in the Department of Biological Effects at the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) in Madrid, where he developed techniques for somatic gene transfer to hematopoieitc stem cells. In 1993 he was an invited researcher at the Center for Blood Research at Harvard Medical School, after which, in 1994, he joined the Centro Nacional de Biotecnología (CNB) in Madrid as a CSIC Científico Titular. At the CNB, first in the Department of Molecular Biology and later in the Department of Immunology and Oncology, he built and directed a research team focused on the biology of hematopoietic and mesechymal stem cells and their use in tissue engineering. In 2006 he was promoted to Profesor de Investigación, the highest category for researchers in the CSIC. In 2007 he moved his research group to the CNIC.